You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

Extra-corporeal Photopheresis in the Management of Graft-Versus-Host Disease in Patients who Have Received Allogeneic Blood or Bone Marrow Transplants: Recommendations

ID: SCT 5 aoû 2013
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
C. Bredeson, R.B. Rumble, N.P. Varela, J. Kuruvilla, C.T. Kouroukis, Stem Cell Transplant Steering Committee

Patient Population

Adult and paediatric patients who have received an allogeneic transplant and are experiencing graft-versus-host disease.

Research Question(s)

Is there a benefit associated with the use of extra-corporeal photopheresis (ECP) compared with other treatment options for patients who have received an allogeneic transplant and are experiencing graft-versus-host disease (GVHD) if response rate, survival, or improvement in symptoms are the outcomes of interest?

pdf download Summary (PDF) (183.6 Ko)
pdf download Full Report (PDF) (606.61 Ko)